Learning how to write a lab instrument validation plan for an AI tool means adapting a familiar structure to an unfamiliar problem: software that updates, retrains, and produces probabilistic outputs. The core elements stay the same as for any regulated instrument: scope, risk assessment, qualification protocols, acceptance criteria, and a summary report. What changes for AI is what goes inside each section, and how the plan accounts for a system that may behave differently tomorrow.
Quick Take:
- A validation plan for an AI tool follows the same structural skeleton as any computer system validation plan: scope, risk assessment, IQ/OQ/PQ, acceptance criteria, and summary report
- Scope definition must specify the AI model version being validated, not just the platform, since a retrained model is functionally a different system
- Risk assessment under computer software assurance (CSA) principles determines how rigorous each subsequent validation activity needs to be
- IQ/OQ/PQ for AI requires additional steps: training data partitioning, performance metric thresholds, and explainability documentation that traditional software validation does not require
- Acceptance criteria for AI must specify quantitative performance thresholds (accuracy, precision, recall) defined before testing begins, not after results are seen
How to write a lab instrument validation plan: what an AI plan should cover
This five-stage AI validation plan outlines the essential milestones—from initial scope definition to final summary reporting—needed to seamlessly integrate artificial intelligence into your lab workflows while minimizing risk.
GEMINI (2026)
A validation plan is the master document that defines what will be tested, why, how, and against what criteria, before any testing begins. Anyone learning how to write a lab instrument validation plan for an AI tool entering regulated laboratory workflows needs the plan to cover six core elements: scope and intended use, risk assessment, qualification protocol structure (IQ/OQ/PQ), acceptance criteria, roles and responsibilities, and the format of the summary report that will close out validation.
The skeleton of this document does not differ from a validation plan for a conventional analytical instrument or LIMS module. What differs is the content within each section, shaped by the GxP validation and data integrity obligations that apply to any AI system touching a regulated record. A spectrophotometer validation plan specifies wavelength accuracy tolerances that will not change between today and next year.
An AI validation plan must account for a system whose behavior may shift the moment its underlying model is retrained, and must define upfront how that possibility will be managed.
Writing the plan before any testing begins is not a formality, and it is the first principle in how to write a lab instrument validation plan correctly. FDA's computer software assurance (CSA) framework explicitly requires that intended use and risk be defined first, with testing scope and depth determined by that risk assessment, not the reverse. A validation plan written after testing has already started, or that retrofits scope to match whatever testing happened to occur, will not withstand inspection scrutiny.
Lab Quality Management Certificate
The Lab Quality Management certificate is more than training—it’s a professional advantage.
Gain critical skills and IACET-approved CEUs that make a measurable difference.
Defining scope: what makes AI validation different
Knowing how to write a lab instrument validation plan starts with scope definition. For any validated system, scope specifies what is being validated, in what configuration, for what intended use. For an AI tool, scope requires one addition that traditional instrument validation does not: the specific model version under validation.
A model retrained on new data, even using the same underlying software platform, is functionally a different system from its predecessor. The validation plan should explicitly identify the model version, the training dataset or data range it was trained on, and the date the model was frozen for validation testing. Without this level of specificity, "validating the AI tool" becomes a moving target that cannot be definitively passed or failed.
Scope should also state what the AI tool's intended use is within the regulated process, expressed in terms specific enough to support testing. Part of how to write a lab instrument validation plan well is precision here: "the AI tool will classify chromatography peaks as conforming or non-conforming based on retention time and peak shape parameters, for use in GMP batch release testing" is a workable scope statement. "The AI tool will assist with chromatography analysis" is not specific enough to design a test protocol against.
Interested in lab leadership?
Finally, scope should define the boundary between validated and non-validated functions if the AI platform includes both. Many commercial AI tools bundle a regulated-record function (such as automated peak classification) with non-regulated convenience features (such as a chat interface for querying historical data). Anyone working through how to write a lab instrument validation plan for such a platform should explicitly state which functions are in scope and which are excluded, with the rationale documented for any exclusion.
Risk assessment for AI systems: a key step in how to write a lab instrument validation plan
The risk assessment determines how much validation effort each function in scope actually requires. Under CSA, risk-based validation frameworks replace the older approach of applying uniform, exhaustive testing to every system regardless of its actual impact on product quality or patient safety.
For AI tools specifically, the risk assessment should evaluate three factors. The first is process risk: what happens if the AI function produces an incorrect output, and is that output independently verified by a human or another system before it affects a regulated decision? The second is patient or product safety risk: does an incorrect AI output have a path to affecting product quality, patient safety, or a regulatory submission?
The third is technical risk specific to AI: how does the model behave at the edges of its training data, and what is the consequence of a low-confidence or out-of-distribution prediction being treated as reliable?
Determining whether a given AI function requires formal validation is itself the output of this risk assessment, and it is a central part of how to write a lab instrument validation plan that targets effort appropriately. A function found to be low-risk, fully human-reviewed, and disconnected from any regulated record may require only lightweight verification. A function that autonomously generates values entered into a batch record requires the full validation rigor described in the rest of this plan.
The risk assessment output should feed directly into the validation plan's testing depth. High-risk functions warrant full IQ/OQ/PQ execution with independent test review. Lower-risk functions may be validated with a reduced protocol, provided the rationale for that reduction is documented in the risk assessment itself, not just asserted in the validation plan.
IQ/OQ/PQ adapted for AI: applying the standard validation plan structure
Installation qualification (IQ), operational qualification (OQ), and performance qualification (PQ) remain the structural backbone of how to write a lab instrument validation plan, and each stage requires AI-specific additions.
IQ for an AI tool confirms that the correct software version and the correct model version are installed in the validated environment, that the model's configuration matches the version frozen during scope definition, and that any data connections feeding the model are configured per specification. Anyone documenting how to write a lab instrument validation plan for AI should also record the hardware or cloud infrastructure the model runs on, since inference behavior can be affected by the computational environment in ways that traditional software is not.
OQ for an AI tool verifies that the system functions correctly across its defined operating range. For traditional software, this typically means testing each function against expected inputs and outputs. For AI, OQ should additionally test the system's behavior at the boundaries of its training data and confirm that out-of-range or anomalous inputs are flagged appropriately rather than silently producing an unreliable output.
This is the stage at which explainability requirements, if applicable, should be tested: can the system surface the basis for a given classification or recommendation sufficiently for a reviewer to evaluate it? This is an element commonly missing from a first attempt at how to write a lab instrument validation plan for AI.
PQ for an AI tool demonstrates that the system performs reliably under real operating conditions, using real or representative production data, over a defined monitoring period. Because AI performance can drift in ways that traditional software does not, PQ for AI tools should incorporate a structured data partitioning approach: separate training, validation, and test datasets, with the test dataset withheld entirely from the model development process.
This ensures the performance figures generated during PQ reflect genuine, unbiased performance rather than memorized results. This is a specific recommendation of the GAMP 5 Appendix D11 guidance on AI/ML validation, and its absence is a common gap inspectors identify in attempts at how to write a lab instrument validation plan for AI systems.
| Qualification stage | Traditional software focus | AI-specific addition |
|---|---|---|
| IQ | Correct software version installed | Correct model version and training data range documented; computational environment specified |
| OQ | Functions perform as specified | Behavior at training data boundaries tested; explainability and anomaly flagging verified |
| PQ | Reliable performance under real conditions | Test dataset held out from training; performance monitored over a defined period to detect drift |
This table captures the core of how to write a lab instrument validation plan for AI: the qualification stages stay fixed, but the AI-specific evidence required at each stage expands the testing scope.
Setting acceptance criteria for AI performance before testing begins
Acceptance criteria must be defined before testing begins, not derived afterward from whatever results testing happens to produce. Part of how to write a lab instrument validation plan for AI tools means specifying quantitative performance thresholds: minimum acceptable accuracy, precision, recall, or false negative rate, depending on which metric is most relevant to the function's intended use and risk profile.
A function flagging potential out-of-specification results for human review might specify a maximum acceptable false negative rate, since missing a true positive carries more risk than generating a false alarm a reviewer can dismiss. Getting this distinction right is central to how to write a lab instrument validation plan that holds up under real-world use. A function autonomously classifying results for direct entry into a batch record requires acceptance criteria for both false positive and false negative rates, since either error type can directly affect a regulated record.
Acceptance criteria should also define what happens when performance falls short during testing. A pre-specified remediation path, retrain and retest, adjust thresholds and retest, or reject the system as unfit for the intended use, prevents acceptance criteria from being quietly renegotiated after a disappointing test result. Knowing how to write a lab instrument validation plan that anticipates this scenario, rather than improvising a response after the fact, is what makes the validation defensible at inspection.
Where the AI tool's outputs become part of an electronic record subject to 21 CFR Part 11, acceptance criteria should also confirm that audit trail fields, electronic signature requirements, and access controls function as required, alongside the AI's analytical performance.
Writing the summary report and releasing the AI tool for use
The validation summary report closes the loop on how to write a lab instrument validation plan: it documents what was tested, against what criteria, with what results, and whether the system is approved for its intended use. For AI tools, the summary report should explicitly restate the model version validated, since this is the detail most likely to become stale or ambiguous if the report is referenced months later during an inspection or a subsequent model update.
The summary report should also document any deviations from the validation plan, their resolution, and any limitations on the system's approved use. If PQ testing revealed degraded performance on a specific sample type or concentration range, that limitation belongs in the summary report and in the system's standard operating procedures, not just in a testing appendix.
Finally, the summary report should establish the change control trigger: what model changes, retraining events, or platform updates will require revalidation, partial or full, before the updated system can resume generating records that depend on its validated status. Without this forward-looking element, the validated status documented in the report has no defined expiration, which is itself a finding waiting to happen.
How to write a lab instrument validation plan for AI: the practical takeaway
Learning how to write a lab instrument validation plan for an AI tool means applying the same disciplined structure used for any regulated instrument: clear scope, documented risk assessment, structured IQ/OQ/PQ, pre-defined acceptance criteria, and a summary report that closes the loop. The differences are concentrated in three places: scope must pin down the specific model version, risk assessment must account for model behavior at the edges of its training data, and PQ must include held-out test data to confirm genuine, unbiased performance. Labs that build these AI-specific elements into their standard validation plan template from the outset will spend less time reworking validation packages later, and they will know how to write a lab instrument validation plan that survives inspection on the first attempt.
This content includes text that has been generated with the assistance of AI. For more information, view Lab Manager's AI use policy.
References
International Society for Pharmaceutical Engineering. GAMP 5: A Risk-Based Approach to Compliant GxP Computerized Systems, Second Edition (includes Appendix D11 on AI/ML). ISPE, 2022. Available at: https://ispe.org/publications/guidance-documents/gamp-5-guide-2nd-edition
U.S. Food and Drug Administration. Good Machine Learning Practice for Medical Device Development: Guiding Principles. Available at: https://www.fda.gov/medical-devices/software-medical-device-samd/good-machine-learning-practice-medical-device-development-guiding-principles
U.S. Code of Federal Regulations. 21 CFR Part 820 — Quality Management System Regulation. Available at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-H/part-820
